Collegium Pharmaceutical (COLL): Low Multiples Justified, Growth To Come At A Cost
RelaxFoto.de Investment Summary Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) have popped onto the radar after the stock rallied 86% of its October 52-week lows. Two, perhaps three main catalysts discussed here look to be responsible […]
